APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI-Assisted Drug Discovery Software

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global AI-Assisted Drug Discovery Software Market Analysis and Forecast 2026-2032

5 June 2026256 pages

Choose your research edition.

Industry ResearchAI-Assisted Drug Discovery Software Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal AI-Assisted Drug Discovery Software Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal AI-Assisted Drug Discovery Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI-Assisted Drug Discovery Software Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal AI-Assisted Drug Discovery Software Market Analysis and Forecast 2026-2032256 pages · $4,950 USD

Market perspective

The global AI-Assisted Drug Discovery Software market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for AI-Assisted Drug Discovery Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for AI-Assisted Drug Discovery Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for AI-Assisted Drug Discovery Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for AI-Assisted Drug Discovery Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of AI-Assisted Drug Discovery Software include AIDDISON, Atomwise Inc, BenevolentAI, BullFrog AI, Cyclica, Exscientia, Genesis Therapeutics Inc, Insilico Medicine and Recursion Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for AI-Assisted Drug Discovery Software, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of AI-Assisted Drug Discovery Software, also provides the revenue of main regions and countries. Of the upcoming market potential for AI-Assisted Drug Discovery Software, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the AI-Assisted Drug Discovery Software revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global AI-Assisted Drug Discovery Software market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for AI-Assisted Drug Discovery Software revenue, projected growth trends, production technology, application and end-user industry.

AI-Assisted Drug Discovery Software Segment by Company

AIDDISON

Atomwise Inc

BenevolentAI

BullFrog AI

Cyclica

Exscientia

Genesis Therapeutics Inc

Insilico Medicine

Recursion Pharmaceuticals

Verge Genomics

AI-Assisted Drug Discovery Software Segment by Type

On Premise Software

Cloud-Based Software

AI-Assisted Drug Discovery Software Segment by Application

Biopharmaceuticals

Pharmaceuticals

Others

AI-Assisted Drug Discovery Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI-Assisted Drug Discovery Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI-Assisted Drug Discovery Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI-Assisted Drug Discovery Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of AI-Assisted Drug Discovery Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of AI-Assisted Drug Discovery Software company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AI-Assisted Drug Discovery Software revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global AI-Assisted Drug Discovery Software Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. On Premise Software Major Player Table 3. Cloud-Based Software Major Player Table 4. Global AI-Assisted Drug Discovery Software Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Biopharmaceuticals Major Player Table 6. Pharmaceuticals Major Player Table 7. Others Major Player Table 8. AI-Assisted Drug Discovery Software Industry Trends Table 9. AI-Assisted Drug Discovery Software Industry Drivers Table 10. AI-Assisted Drug Discovery Software Industry Opportunities and Challenges Table 11. AI-Assisted Drug Discovery Software Industry Restraints Table 12. Global AI-Assisted Drug Discovery Software Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global AI-Assisted Drug Discovery Software Market Size by Region (2021-2026) & (US$ Million) Table 14. Global AI-Assisted Drug Discovery Software Market Share by Region (2021-2026) Table 15. Global AI-Assisted Drug Discovery Software Market Size by Region (2027-2032) & (US$ Million) Table 16. Global AI-Assisted Drug Discovery Software Market Share by Region (2027-2032) Table 17. Global AI-Assisted Drug Discovery Software Revenue by Players (US$ Million) & (2021-2026) Table 18. Global AI-Assisted Drug Discovery Software Revenue Market Share by Players (2021-2026) Table 19. Global AI-Assisted Drug Discovery Software Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global AI-Assisted Drug Discovery Software Key Players Headquarters & Area Served Table 21. Global AI-Assisted Drug Discovery Software Players, Product Type & Application Table 22. Global AI-Assisted Drug Discovery Software Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global AI-Assisted Drug Discovery Software by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global AI-Assisted Drug Discovery Software Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global AI-Assisted Drug Discovery Software Revenue by Type (2021-2026) & (US$ Million) Table 27. Global AI-Assisted Drug Discovery Software Revenue by Type (2027-2032) & (US$ Million) Table 28. Global AI-Assisted Drug Discovery Software Revenue Market Share by Type (2021-2026) Table 29. Global AI-Assisted Drug Discovery Software Revenue Market Share by Type (2027-2032) Table 30. Global AI-Assisted Drug Discovery Software Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global AI-Assisted Drug Discovery Software Revenue by Application (2021-2026) & (US$ Million) Table 32. Global AI-Assisted Drug Discovery Software Revenue by Application (2027-2032) & (US$ Million) Table 33. Global AI-Assisted Drug Discovery Software Revenue Market Share by Application (2021-2026) Table 34. Global AI-Assisted Drug Discovery Software Revenue Market Share by Application (2027-2032) Table 35. AIDDISON Company Information Table 36. AIDDISON Business Overview Table 37. AIDDISON AI-Assisted Drug Discovery Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. AIDDISON AI-Assisted Drug Discovery Software Product Portfolio Table 39. AIDDISON Recent Development Table 40. Atomwise Inc Company Information Table 41. Atomwise Inc Business Overview Table 42. Atomwise Inc AI-Assisted Drug Discovery Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Atomwise Inc AI-Assisted Drug Discovery Software Product Portfolio Table 44. Atomwise Inc Recent Development Table 45. BenevolentAI Company Information Table 46. BenevolentAI Business Overview Table 47. BenevolentAI AI-Assisted Drug Discovery Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. BenevolentAI AI-Assisted Drug Discovery Software Product Portfolio Table 49. BenevolentAI Recent Development Table 50. BullFrog AI Company Information Table 51. BullFrog AI Business Overview Table 52. BullFrog AI AI-Assisted Drug Discovery Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. BullFrog AI AI-Assisted Drug Discovery Software Product Portfolio Table 54. BullFrog AI Recent Development Table 55. Cyclica Company Information Table 56. Cyclica Business Overview Table 57. Cyclica AI-Assisted Drug Discovery Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Cyclica AI-Assisted Drug Discovery Software Product Portfolio Table 59. Cyclica Recent Development Table 60. Exscientia Company Information Table 61. Exscientia Business Overview Table 62. Exscientia AI-Assisted Drug Discovery Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Exscientia AI-Assisted Drug Discovery Software Product Portfolio Table 64. Exscientia Recent Development Table 65. Genesis Therapeutics Inc Company Information Table 66. Genesis Therapeutics Inc Business Overview Table 67. Genesis Therapeutics Inc AI-Assisted Drug Discovery Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Genesis Therapeutics Inc AI-Assisted Drug Discovery Software Product Portfolio Table 69. Genesis Therapeutics Inc Recent Development Table 70. Insilico Medicine Company Information Table 71. Insilico Medicine Business Overview Table 72. Insilico Medicine AI-Assisted Drug Discovery Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Insilico Medicine AI-Assisted Drug Discovery Software Product Portfolio Table 74. Insilico Medicine Recent Development Table 75. Recursion Pharmaceuticals Company Information Table 76. Recursion Pharmaceuticals Business Overview Table 77. Recursion Pharmaceuticals AI-Assisted Drug Discovery Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Recursion Pharmaceuticals AI-Assisted Drug Discovery Software Product Portfolio Table 79. Recursion Pharmaceuticals Recent Development Table 80. Verge Genomics Company Information Table 81. Verge Genomics Business Overview Table 82. Verge Genomics AI-Assisted Drug Discovery Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Verge Genomics AI-Assisted Drug Discovery Software Product Portfolio Table 84. Verge Genomics Recent Development Table 85. North America AI-Assisted Drug Discovery Software Revenue by Type (2021-2026) & (US$ Million) Table 86. North America AI-Assisted Drug Discovery Software Revenue by Type (2027-2032) & (US$ Million) Table 87. North America AI-Assisted Drug Discovery Software Revenue by Application (2021-2026) & (US$ Million) Table 88. North America AI-Assisted Drug Discovery Software Revenue by Application (2027-2032) & (US$ Million) Table 89. North America AI-Assisted Drug Discovery Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 90. North America AI-Assisted Drug Discovery Software Revenue by Country (2021-2026) & (US$ Million) Table 91. North America AI-Assisted Drug Discovery Software Revenue by Country (US$ Million) & (2027-2032) Table 92. Europe AI-Assisted Drug Discovery Software Revenue by Type (2021-2026) & (US$ Million) Table 93. Europe AI-Assisted Drug Discovery Software Revenue by Type (2027-2032) & (US$ Million) Table 94. Europe AI-Assisted Drug Discovery Software Revenue by Application (2021-2026) & (US$ Million) Table 95. Europe AI-Assisted Drug Discovery Software Revenue by Application (2027-2032) & (US$ Million) Table 96. Europe AI-Assisted Drug Discovery Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. Europe AI-Assisted Drug Discovery Software Revenue by Country (2021-2026) & (US$ Million) Table 98. Europe AI-Assisted Drug Discovery Software Revenue by Country (US$ Million) & (2027-2032) Table 99. China AI-Assisted Drug Discovery Software Revenue by Type (2021-2026) & (US$ Million) Table 100. China AI-Assisted Drug Discovery Software Revenue by Type (2027-2032) & (US$ Million) Table 101. China AI-Assisted Drug Discovery Software Revenue by Application (2021-2026) & (US$ Million) Table 102. China AI-Assisted Drug Discovery Software Revenue by Application (2027-2032) & (US$ Million) Table 103. Asia AI-Assisted Drug Discovery Software Revenue by Type (2021-2026) & (US$ Million) Table 104. Asia AI-Assisted Drug Discovery Software Revenue by Type (2027-2032) & (US$ Million) Table 105. Asia AI-Assisted Drug Discovery Software Revenue by Application (2021-2026) & (US$ Million) Table 106. Asia AI-Assisted Drug Discovery Software Revenue by Application (2027-2032) & (US$ Million) Table 107. Asia AI-Assisted Drug Discovery Software Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Asia AI-Assisted Drug Discovery Software Revenue by Region (US$ Million) & (2021-2026) Table 109. Asia AI-Assisted Drug Discovery Software Revenue by Region (US$ Million) & (2027-2032) Table 110. SAMEA AI-Assisted Drug Discovery Software Revenue by Type (2021-2026) & (US$ Million) Table 111. SAMEA AI-Assisted Drug Discovery Software Revenue by Type (2027-2032) & (US$ Million) Table 112. SAMEA AI-Assisted Drug Discovery Software Revenue by Application (2021-2026) & (US$ Million) Table 113. SAMEA AI-Assisted Drug Discovery Software Revenue by Application (2027-2032) & (US$ Million) Table 114. SAMEA AI-Assisted Drug Discovery Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. SAMEA AI-Assisted Drug Discovery Software Revenue by Country (2021-2026) & (US$ Million) Table 116. SAMEA AI-Assisted Drug Discovery Software Revenue by Country (US$ Million) & (2027-2032) Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. AI-Assisted Drug Discovery Software Image Figure 2. Global AI-Assisted Drug Discovery Software Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AI-Assisted Drug Discovery Software Market Size Share 2021 VS 2025 VS 2032 Figure 4. On Premise Software Image Figure 5. Cloud-Based Software Image Figure 6. Global AI-Assisted Drug Discovery Software Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global AI-Assisted Drug Discovery Software Market Size Share 2021 VS 2025 VS 2032 Figure 8. Biopharmaceuticals Image Figure 9. Pharmaceuticals Image Figure 10. Others Image Figure 11. Global AI-Assisted Drug Discovery Software Market Size (US$ Million) & (2021-2032) Figure 12. Global AI-Assisted Drug Discovery Software Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global AI-Assisted Drug Discovery Software Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global AI-Assisted Drug Discovery Software Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global AI-Assisted Drug Discovery Software Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global AI-Assisted Drug Discovery Software Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global AI-Assisted Drug Discovery Software Revenue Market Share by Type (2021-2032) Figure 19. Global AI-Assisted Drug Discovery Software Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global AI-Assisted Drug Discovery Software Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global AI-Assisted Drug Discovery Software Revenue Market Share by Application (2021-2032) Figure 22. North America AI-Assisted Drug Discovery Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America AI-Assisted Drug Discovery Software Revenue Share by Type (2021-2032) Figure 24. North America AI-Assisted Drug Discovery Software Revenue Share by Application (2021-2032) Figure 25. North America AI-Assisted Drug Discovery Software Revenue Share by Country (2021-2032) Figure 26. United States AI-Assisted Drug Discovery Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada AI-Assisted Drug Discovery Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico AI-Assisted Drug Discovery Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe AI-Assisted Drug Discovery Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe AI-Assisted Drug Discovery Software Revenue Share by Type (2021-2032) Figure 31. Europe AI-Assisted Drug Discovery Software Revenue Share by Application (2021-2032) Figure 32. Europe AI-Assisted Drug Discovery Software Revenue Share by Country (2021-2032) Figure 33. Germany AI-Assisted Drug Discovery Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France AI-Assisted Drug Discovery Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. AI-Assisted Drug Discovery Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy AI-Assisted Drug Discovery Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain AI-Assisted Drug Discovery Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia AI-Assisted Drug Discovery Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands AI-Assisted Drug Discovery Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries AI-Assisted Drug Discovery Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China AI-Assisted Drug Discovery Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China AI-Assisted Drug Discovery Software Revenue Share by Type (2021-2032) Figure 43. China AI-Assisted Drug Discovery Software Revenue Share by Application (2021-2032) Figure 44. Asia AI-Assisted Drug Discovery Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia AI-Assisted Drug Discovery Software Revenue Share by Type (2021-2032) Figure 46. Asia AI-Assisted Drug Discovery Software Revenue Share by Application (2021-2032) Figure 47. Asia AI-Assisted Drug Discovery Software Revenue Share by Region (2021-2032) Figure 48. Japan AI-Assisted Drug Discovery Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea AI-Assisted Drug Discovery Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India AI-Assisted Drug Discovery Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia AI-Assisted Drug Discovery Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan AI-Assisted Drug Discovery Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia AI-Assisted Drug Discovery Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA AI-Assisted Drug Discovery Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA AI-Assisted Drug Discovery Software Revenue Share by Type (2021-2032) Figure 56. SAMEA AI-Assisted Drug Discovery Software Revenue Share by Application (2021-2032) Figure 57. SAMEA AI-Assisted Drug Discovery Software Revenue Share by Country (2021-2032) Figure 58. Brazil AI-Assisted Drug Discovery Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina AI-Assisted Drug Discovery Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile AI-Assisted Drug Discovery Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia AI-Assisted Drug Discovery Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru AI-Assisted Drug Discovery Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia AI-Assisted Drug Discovery Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel AI-Assisted Drug Discovery Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE AI-Assisted Drug Discovery Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey AI-Assisted Drug Discovery Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran AI-Assisted Drug Discovery Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt AI-Assisted Drug Discovery Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • On Premise Software
  • Cloud-Based Software
Applications
  • Biopharmaceuticals
  • Pharmaceuticals
  • Others
Companies covered
  • AIDDISON
  • Atomwise Inc
  • BenevolentAI
  • BullFrog AI
  • Cyclica
  • Exscientia
  • Genesis Therapeutics Inc
  • Insilico Medicine
  • Recursion Pharmaceuticals
  • Verge Genomics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 AI-Assisted Drug Discovery Software Market by Type
  3. 1.2.1 Global AI-Assisted Drug Discovery Software Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 On Premise Software
  5. 1.2.3 Cloud-Based Software
  6. 1.3 AI-Assisted Drug Discovery Software Market by Application
  7. 1.3.1 Global AI-Assisted Drug Discovery Software Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Biopharmaceuticals
  9. 1.3.3 Pharmaceuticals
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 AI-Assisted Drug Discovery Software Market Dynamics
  1. 2.1 AI-Assisted Drug Discovery Software Industry Trends
  2. 2.2 AI-Assisted Drug Discovery Software Industry Drivers
  3. 2.3 AI-Assisted Drug Discovery Software Industry Opportunities and Challenges
  4. 2.4 AI-Assisted Drug Discovery Software Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global AI-Assisted Drug Discovery Software Market Perspective (2021-2032)
  2. 3.2 Global AI-Assisted Drug Discovery Software Growth Trends by Region
  3. 3.2.1 Global AI-Assisted Drug Discovery Software Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global AI-Assisted Drug Discovery Software Market Size by Region (2021-2026)
  5. 3.2.3 Global AI-Assisted Drug Discovery Software Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global AI-Assisted Drug Discovery Software Revenue by Players
  2. 4.1.1 Global AI-Assisted Drug Discovery Software Revenue by Players (2021-2026)
  3. 4.1.2 Global AI-Assisted Drug Discovery Software Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global AI-Assisted Drug Discovery Software Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global AI-Assisted Drug Discovery Software Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global AI-Assisted Drug Discovery Software Key Players Headquarters & Area Served
  7. 4.4 Global AI-Assisted Drug Discovery Software Players, Product Type & Application
  8. 4.5 Global AI-Assisted Drug Discovery Software Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global AI-Assisted Drug Discovery Software Market CR5 and HHI
  11. 4.6.3 2025 AI-Assisted Drug Discovery Software Tier 1, Tier 2, and Tier 3
5 AI-Assisted Drug Discovery Software Market Size by Type
  1. 5.1 Global AI-Assisted Drug Discovery Software Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global AI-Assisted Drug Discovery Software Revenue by Type (2021-2032)
  3. 5.3 Global AI-Assisted Drug Discovery Software Revenue Market Share by Type (2021-2032)
6 AI-Assisted Drug Discovery Software Market Size by Application
  1. 6.1 Global AI-Assisted Drug Discovery Software Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global AI-Assisted Drug Discovery Software Revenue by Application (2021-2032)
  3. 6.3 Global AI-Assisted Drug Discovery Software Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 AIDDISON
  2. 7.1.1 AIDDISON Company Information
  3. 7.1.2 AIDDISON Business Overview
  4. 7.1.3 AIDDISON AI-Assisted Drug Discovery Software Revenue and Gross Margin (2021-2026)
  5. 7.1.4 AIDDISON AI-Assisted Drug Discovery Software Product Portfolio
  6. 7.1.5 AIDDISON Recent Developments
  7. 7.2 Atomwise Inc
  8. 7.2.1 Atomwise Inc Company Information
  9. 7.2.2 Atomwise Inc Business Overview
  10. 7.2.3 Atomwise Inc AI-Assisted Drug Discovery Software Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Atomwise Inc AI-Assisted Drug Discovery Software Product Portfolio
  12. 7.2.5 Atomwise Inc Recent Developments
  13. 7.3 BenevolentAI
  14. 7.3.1 BenevolentAI Company Information
  15. 7.3.2 BenevolentAI Business Overview
  16. 7.3.3 BenevolentAI AI-Assisted Drug Discovery Software Revenue and Gross Margin (2021-2026)
  17. 7.3.4 BenevolentAI AI-Assisted Drug Discovery Software Product Portfolio
  18. 7.3.5 BenevolentAI Recent Developments
  19. 7.4 BullFrog AI
  20. 7.4.1 BullFrog AI Company Information
  21. 7.4.2 BullFrog AI Business Overview
  22. 7.4.3 BullFrog AI AI-Assisted Drug Discovery Software Revenue and Gross Margin (2021-2026)
  23. 7.4.4 BullFrog AI AI-Assisted Drug Discovery Software Product Portfolio
  24. 7.4.5 BullFrog AI Recent Developments
  25. 7.5 Cyclica
  26. 7.5.1 Cyclica Company Information
  27. 7.5.2 Cyclica Business Overview
  28. 7.5.3 Cyclica AI-Assisted Drug Discovery Software Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Cyclica AI-Assisted Drug Discovery Software Product Portfolio
  30. 7.5.5 Cyclica Recent Developments
  31. 7.6 Exscientia
  32. 7.6.1 Exscientia Company Information
  33. 7.6.2 Exscientia Business Overview
  34. 7.6.3 Exscientia AI-Assisted Drug Discovery Software Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Exscientia AI-Assisted Drug Discovery Software Product Portfolio
  36. 7.6.5 Exscientia Recent Developments
  37. 7.7 Genesis Therapeutics Inc
  38. 7.7.1 Genesis Therapeutics Inc Company Information
  39. 7.7.2 Genesis Therapeutics Inc Business Overview
  40. 7.7.3 Genesis Therapeutics Inc AI-Assisted Drug Discovery Software Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Genesis Therapeutics Inc AI-Assisted Drug Discovery Software Product Portfolio
  42. 7.7.5 Genesis Therapeutics Inc Recent Developments
  43. 7.8 Insilico Medicine
  44. 7.8.1 Insilico Medicine Company Information
  45. 7.8.2 Insilico Medicine Business Overview
  46. 7.8.3 Insilico Medicine AI-Assisted Drug Discovery Software Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Insilico Medicine AI-Assisted Drug Discovery Software Product Portfolio
  48. 7.8.5 Insilico Medicine Recent Developments
  49. 7.9 Recursion Pharmaceuticals
  50. 7.9.1 Recursion Pharmaceuticals Company Information
  51. 7.9.2 Recursion Pharmaceuticals Business Overview
  52. 7.9.3 Recursion Pharmaceuticals AI-Assisted Drug Discovery Software Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Recursion Pharmaceuticals AI-Assisted Drug Discovery Software Product Portfolio
  54. 7.9.5 Recursion Pharmaceuticals Recent Developments
  55. 7.10 Verge Genomics
  56. 7.10.1 Verge Genomics Company Information
  57. 7.10.2 Verge Genomics Business Overview
  58. 7.10.3 Verge Genomics AI-Assisted Drug Discovery Software Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Verge Genomics AI-Assisted Drug Discovery Software Product Portfolio
  60. 7.10.5 Verge Genomics Recent Developments
8 North America
  1. 8.1 North America AI-Assisted Drug Discovery Software Revenue (2021-2032)
  2. 8.2 North America AI-Assisted Drug Discovery Software Revenue by Type (2021-2032)
  3. 8.2.1 North America AI-Assisted Drug Discovery Software Revenue by Type (2021-2026)
  4. 8.2.2 North America AI-Assisted Drug Discovery Software Revenue by Type (2027-2032)
  5. 8.3 North America AI-Assisted Drug Discovery Software Revenue Share by Type (2021-2032)
  6. 8.4 North America AI-Assisted Drug Discovery Software Revenue by Application (2021-2032)
  7. 8.4.1 North America AI-Assisted Drug Discovery Software Revenue by Application (2021-2026)
  8. 8.4.2 North America AI-Assisted Drug Discovery Software Revenue by Application (2027-2032)
  9. 8.5 North America AI-Assisted Drug Discovery Software Revenue Share by Application (2021-2032)
  10. 8.6 North America AI-Assisted Drug Discovery Software Revenue by Country
  11. 8.6.1 North America AI-Assisted Drug Discovery Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America AI-Assisted Drug Discovery Software Revenue by Country (2021-2026)
  13. 8.6.3 North America AI-Assisted Drug Discovery Software Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe AI-Assisted Drug Discovery Software Revenue (2021-2032)
  2. 9.2 Europe AI-Assisted Drug Discovery Software Revenue by Type (2021-2032)
  3. 9.2.1 Europe AI-Assisted Drug Discovery Software Revenue by Type (2021-2026)
  4. 9.2.2 Europe AI-Assisted Drug Discovery Software Revenue by Type (2027-2032)
  5. 9.3 Europe AI-Assisted Drug Discovery Software Revenue Share by Type (2021-2032)
  6. 9.4 Europe AI-Assisted Drug Discovery Software Revenue by Application (2021-2032)
  7. 9.4.1 Europe AI-Assisted Drug Discovery Software Revenue by Application (2021-2026)
  8. 9.4.2 Europe AI-Assisted Drug Discovery Software Revenue by Application (2027-2032)
  9. 9.5 Europe AI-Assisted Drug Discovery Software Revenue Share by Application (2021-2032)
  10. 9.6 Europe AI-Assisted Drug Discovery Software Revenue by Country
  11. 9.6.1 Europe AI-Assisted Drug Discovery Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe AI-Assisted Drug Discovery Software Revenue by Country (2021-2026)
  13. 9.6.3 Europe AI-Assisted Drug Discovery Software Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China AI-Assisted Drug Discovery Software Revenue (2021-2032)
  2. 10.2 China AI-Assisted Drug Discovery Software Revenue by Type (2021-2032)
  3. 10.2.1 China AI-Assisted Drug Discovery Software Revenue by Type (2021-2026)
  4. 10.2.2 China AI-Assisted Drug Discovery Software Revenue by Type (2027-2032)
  5. 10.3 China AI-Assisted Drug Discovery Software Revenue Share by Type (2021-2032)
  6. 10.4 China AI-Assisted Drug Discovery Software Revenue by Application (2021-2032)
  7. 10.4.1 China AI-Assisted Drug Discovery Software Revenue by Application (2021-2026)
  8. 10.4.2 China AI-Assisted Drug Discovery Software Revenue by Application (2027-2032)
  9. 10.5 China AI-Assisted Drug Discovery Software Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia AI-Assisted Drug Discovery Software Revenue (2021-2032)
  2. 11.2 Asia AI-Assisted Drug Discovery Software Revenue by Type (2021-2032)
  3. 11.2.1 Asia AI-Assisted Drug Discovery Software Revenue by Type (2021-2026)
  4. 11.2.2 Asia AI-Assisted Drug Discovery Software Revenue by Type (2027-2032)
  5. 11.3 Asia AI-Assisted Drug Discovery Software Revenue Share by Type (2021-2032)
  6. 11.4 Asia AI-Assisted Drug Discovery Software Revenue by Application (2021-2032)
  7. 11.4.1 Asia AI-Assisted Drug Discovery Software Revenue by Application (2021-2026)
  8. 11.4.2 Asia AI-Assisted Drug Discovery Software Revenue by Application (2027-2032)
  9. 11.5 Asia AI-Assisted Drug Discovery Software Revenue Share by Application (2021-2032)
  10. 11.6 Asia AI-Assisted Drug Discovery Software Revenue by Country
  11. 11.6.1 Asia AI-Assisted Drug Discovery Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia AI-Assisted Drug Discovery Software Revenue by Country (2021-2026)
  13. 11.6.3 Asia AI-Assisted Drug Discovery Software Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA AI-Assisted Drug Discovery Software Revenue (2021-2032)
  2. 12.2 SAMEA AI-Assisted Drug Discovery Software Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA AI-Assisted Drug Discovery Software Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA AI-Assisted Drug Discovery Software Revenue by Type (2027-2032)
  5. 12.3 SAMEA AI-Assisted Drug Discovery Software Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA AI-Assisted Drug Discovery Software Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA AI-Assisted Drug Discovery Software Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA AI-Assisted Drug Discovery Software Revenue by Application (2027-2032)
  9. 12.5 SAMEA AI-Assisted Drug Discovery Software Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA AI-Assisted Drug Discovery Software Revenue by Country
  11. 12.6.1 SAMEA AI-Assisted Drug Discovery Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA AI-Assisted Drug Discovery Software Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA AI-Assisted Drug Discovery Software Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst